195 related articles for article (PubMed ID: 34351590)
1. Oliceridine Exhibits Improved Tolerability Compared to Morphine at Equianalgesic Conditions: Exploratory Analysis from Two Phase 3 Randomized Placebo and Active Controlled Trials.
Hammer GB; Khanna AK; Michalsky C; Wase L; Demitrack MA; Little R; Fossler MJ; Ayad S
Pain Ther; 2021 Dec; 10(2):1343-1353. PubMed ID: 34351590
[TBL] [Abstract][Full Text] [Related]
2. Oliceridine is Associated with Reduced Risk of Vomiting and Need for Rescue Antiemetics Compared to Morphine: Exploratory Analysis from Two Phase 3 Randomized Placebo and Active Controlled Trials.
Beard TL; Michalsky C; Candiotti KA; Rider P; Wase L; Habib AS; Demitrack MA; Fossler MJ; Viscusi ER
Pain Ther; 2021 Jun; 10(1):401-413. PubMed ID: 33210266
[TBL] [Abstract][Full Text] [Related]
3. APOLLO-2: A Randomized, Placebo and Active-Controlled Phase III Study Investigating Oliceridine (TRV130), a G Protein-Biased Ligand at the μ-Opioid Receptor, for Management of Moderate to Severe Acute Pain Following Abdominoplasty.
Singla NK; Skobieranda F; Soergel DG; Salamea M; Burt DA; Demitrack MA; Viscusi ER
Pain Pract; 2019 Sep; 19(7):715-731. PubMed ID: 31162798
[TBL] [Abstract][Full Text] [Related]
4. APOLLO-1: a randomized placebo and active-controlled phase III study investigating oliceridine (TRV130), a G protein-biased ligand at the µ-opioid receptor, for management of moderate-to-severe acute pain following bunionectomy.
Viscusi ER; Skobieranda F; Soergel DG; Cook E; Burt DA; Singla N
J Pain Res; 2019; 12():927-943. PubMed ID: 30881102
[TBL] [Abstract][Full Text] [Related]
5. Low Incidence of Postoperative Respiratory Depression with Oliceridine Compared to Morphine: A Retrospective Chart Analysis.
Bergese S; Berkowitz R; Rider P; Ladouceur M; Griffith S; Segura Vasi A; Cochrane K; Wase L; Demitrack MA; Habib AS
Pain Res Manag; 2020; 2020():7492865. PubMed ID: 33163127
[TBL] [Abstract][Full Text] [Related]
6. A randomized, Phase IIb study investigating oliceridine (TRV130), a novel µ-receptor G-protein pathway selective (μ-GPS) modulator, for the management of moderate to severe acute pain following abdominoplasty.
Singla N; Minkowitz HS; Soergel DG; Burt DA; Subach RA; Salamea MY; Fossler MJ; Skobieranda F
J Pain Res; 2017; 10():2413-2424. PubMed ID: 29062240
[TBL] [Abstract][Full Text] [Related]
7. Oliceridine: A Novel Drug for the Management of Moderate to Severe Acute Pain - A Review of Current Evidence.
Tan HS; Habib AS
J Pain Res; 2021; 14():969-979. PubMed ID: 33889018
[TBL] [Abstract][Full Text] [Related]
8. Evaluating the Incidence of Opioid-Induced Respiratory Depression Associated with Oliceridine and Morphine as Measured by the Frequency and Average Cumulative Duration of Dosing Interruption in Patients Treated for Acute Postoperative Pain.
Ayad S; Demitrack MA; Burt DA; Michalsky C; Wase L; Fossler MJ; Khanna AK
Clin Drug Investig; 2020 Aug; 40(8):755-764. PubMed ID: 32583295
[TBL] [Abstract][Full Text] [Related]
9. Oliceridine for the Management of Acute Postoperative Pain.
Liu Y; Hu Q; Yang J
Ann Pharmacother; 2021 Oct; 55(10):1283-1289. PubMed ID: 33423508
[TBL] [Abstract][Full Text] [Related]
10. Efficacy and safety of oliceridine treatment in patients with postoperative pain: a systematic review and meta-analysis of randomized controlled trials.
Niu J; Hu W; Lu Y; Tang H
Expert Rev Clin Pharmacol; 2023; 16(6):589-599. PubMed ID: 37171148
[TBL] [Abstract][Full Text] [Related]
11. Oliceridine for the Management of Moderate to Severe Acute Postoperative Pain: A Narrative Review.
Daksla N; Wang A; Jin Z; Gupta A; Bergese SD
Drug Des Devel Ther; 2023; 17():875-886. PubMed ID: 36987403
[TBL] [Abstract][Full Text] [Related]
12. ATHENA: A Phase 3, Open-Label Study Of The Safety And Effectiveness Of Oliceridine (TRV130), A G-Protein Selective Agonist At The µ-Opioid Receptor, In Patients With Moderate To Severe Acute Pain Requiring Parenteral Opioid Therapy.
Bergese SD; Brzezinski M; Hammer GB; Beard TL; Pan PH; Mace SE; Berkowitz RD; Cochrane K; Wase L; Minkowitz HS; Habib AS
J Pain Res; 2019; 12():3113-3126. PubMed ID: 31814753
[TBL] [Abstract][Full Text] [Related]
13. Oliceridine, a G protein-selective ligand at the μ-opioid receptor, for the management of moderate to severe acute pain.
Gan TJ; Wase L
Drugs Today (Barc); 2020 Apr; 56(4):269-286. PubMed ID: 32309822
[TBL] [Abstract][Full Text] [Related]
14. Budget impact and pharmacy costs with targeted use of oliceridine for postsurgical pain in patients at high risk of opioid-related adverse events.
Simpson KN; Fossler MJ; Wase L; Demitrack MA; Wandstrat TL
Expert Rev Pharmacoecon Outcomes Res; 2022 Jun; 22(4):671-681. PubMed ID: 35129031
[TBL] [Abstract][Full Text] [Related]
15. Cost-effectiveness and cost-benefit analysis of oliceridine in the treatment of acute pain.
Simpson KN; Fossler MJ; Wase L; Demitrack MA
J Comp Eff Res; 2021 Oct; 10(15):1107-1119. PubMed ID: 34240625
[TBL] [Abstract][Full Text] [Related]
16. Neurocognitive Effect of Biased µ-Opioid Receptor Agonist Oliceridine, a Utility Function Analysis and Comparison with Morphine.
Moss L; Hijma H; Demitrack M; Kim J; Groeneveld GJ; van Velzen M; Niesters M; Olofsen E; Dahan A
Anesthesiology; 2023 Dec; 139(6):746-756. PubMed ID: 37656771
[TBL] [Abstract][Full Text] [Related]
17. Benefit and Risk Evaluation of Biased μ-Receptor Agonist Oliceridine versus Morphine.
Dahan A; van Dam CJ; Niesters M; van Velzen M; Fossler MJ; Demitrack MA; Olofsen E
Anesthesiology; 2020 Sep; 133(3):559-568. PubMed ID: 32788558
[TBL] [Abstract][Full Text] [Related]
18. Evaluating oliceridine as a treatment option for moderate to severe acute post-operative pain in adults.
Jin Z; Zhu M; Gupta A; Page C; Gan TJ; Bergese SD
Expert Opin Pharmacother; 2022 Jan; 23(1):9-17. PubMed ID: 34534033
[TBL] [Abstract][Full Text] [Related]
19. A critical review of oliceridine injection as an IV opioid analgesic for the management of severe acute pain.
Viscusi ER
Expert Rev Neurother; 2022 Jun; 22(6):419-426. PubMed ID: 35502668
[TBL] [Abstract][Full Text] [Related]
20. Preclinical discovery and development of oliceridine (Olinvyk®) for the treatment of post-operative pain.
Azzam AAH; Lambert DG
Expert Opin Drug Discov; 2022 Mar; 17(3):215-223. PubMed ID: 34817313
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
